A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

A new blood test may help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

pancreatic fistula (PF), metabolic syndrome (MS), and pancreatic duct adenocarcinoma (PDAC) (1). In addition, the lack of consensus on the terminology used to describe this condition has led to ...

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China ...

Relationship of circulating tumor DNA (ctDNA) tumor fraction with prognosis in patients with metastatic pancreatobiliary cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

Pancreatic cancer is one of the deadliest forms of cancer, with survival rates remaining alarmingly low. Only 12% of men and 14% of women diagnosed with the disease survive beyond five years.

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%. In pancreatic cancer, symptoms ...